Emma Richman, Global Writer Additional reporting by Natalie Strain For around a 65-hour period beginning May 1, a Louisiana lawsuit against the Food and Drug Administration (FDA) shut down nationwide access to an abortion pill by mail. The New Orleans-based 5th Circuit Court of Appeals banned access to the drug—mifepristone—by mail, and the Supreme Court…